Predicted Strain Coverage of a New Meningococcal Multicomponent Vaccine (4CMenB) in Spain: Analysis of the Differences with Other European Countries

BACKGROUND: A novel meningococcal multicomponent vaccine, 4CMenB (Bexsero(®)), has been approved in Europe, Canada, Australia and US. The potential impact of 4CMenB on strain coverage is being estimated by using Meningococcal Antigen Typing System (MATS), an ELISA assay which measures vaccine antige...

Descripción completa

Detalles Bibliográficos
Autores principales: Abad, Raquel, Medina, Verónica, Stella, Maria, Boccadifuoco, Giuseppe, Comanducci, Maurizio, Bambini, Stefania, Muzzi, Alessandro, Vázquez, Julio A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780694/
https://www.ncbi.nlm.nih.gov/pubmed/26950303
http://dx.doi.org/10.1371/journal.pone.0150721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780694/
https://www.ncbi.nlm.nih.gov/pubmed/26950303
http://dx.doi.org/10.1371/journal.pone.0150721

Ejemplares similares